Andrew Quinn
Papers
1
Total Citations
14
H-Index
1
About
Andrew Quinn’s research has centered on advancing the accuracy and efficiency of molecular diagnostics for sexually transmitted infections, with a particular focus on *Chlamydia trachomatis* and *Neisseria gonorrhoeae*. His major contribution lies in validating automated extraction technologies for clinical use, most notably through his work on the MagNA Pure LC robot. In his highly cited 2004 study, Quinn demonstrated that this robotic system could reliably extract DNA from both uncentrifuged urine and cervical swab specimens, achieving sensitivity and specificity comparable to the gold-standard Amplicor method. By analyzing over 1,000 clinical samples across multiple cohorts, he proved that automation could streamline high-throughput testing without compromising diagnostic accuracy. This work directly addressed a critical bottleneck in clinical laboratories, enabling faster, more consistent processing of large specimen volumes. While his citation count of 14 reflects a focused, technical contribution rather than broad visibility, its impact is deeply felt in the field of clinical microbiology, where his validation data has supported the adoption of robotic extraction for routine STI screening. Quinn’s research exemplifies how rigorous method validation can translate into tangible improvements in public health diagnostics.
Research Focus
Key Achievements
Top Papers
- 1